Perforated peptic ulcer: to close or patch - a century-old controversy
Khalid Mahmoud1, Mohamad K Abou Chaar1, Daniel Stephens1
1Surgery Research Office; Division of Trauma, Critical Care, and General Surgery, Department of Surgery, Mayo Clinic, Rochester, MN, United States.
Background:
This study aimed to determine which surgical technique is associated with more favorable outcomes for the repair of perforated peptic ulcers.
Methods:
A retrospective medical record review of patients who underwent surgery for perforated peptic ulcers at the Mayo Clinic Rochester campus between 2004 and 2021 was performed.
Results:
The final analysis included 277 patients: 182 underwent suture closure of the perforation, 55 underwent patch-only repair, 15 underwent gastrectomy with reconstruction, 14 underwent wedge resection, and 11 underwent other techniques. No leaks were observed in patients who underwent stapled wedge resection. Among patients who underwent repair of the perforation (n = 237), 3 variables associated with the leak on univariate analysis were included in a logistic regression model. All 3 variables were independently associated with a leak: lack of suture closure of the perforation (odds ratio [OR], 7.0; 95% CI, 2.5-19.1), immunosuppression (OR, 5.5; 95% CI, 1.7-17.6), and lactate levels (OR, 1.4; 95% CI, 1.1-1.7).
Conclusion:
When both sutured and patch-only closure techniques are feasible for a perforated peptic ulcer, sutured closure is associated with a lower risk of leakage. However, given our study's retrospective, single-institution nature, the findings should be interpreted with caution.
More Related Videos
Related Concept Videos
Peptic Ulcer Disease V: Surgical Management and Nursing Care
Surgical Interventions for Peptic Ulcer Disease
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Esophageal Perforation-II: Clinical Manifestations and Management
Clinical Manifestations:
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...


